GlaxoSmithKline wins blockbuster green light for Shingrix, its new shingles vaccine

20th October 2017 Uncategorised 0

GlaxoSmithKline has the official go-ahead for its next big launch. Late Friday, the FDA approved the company’s new shingles vaccine, Shingrix, setting up a market duel with blockbuster implications between GSK and Merck.

More: GlaxoSmithKline wins blockbuster green light for Shingrix, its new shingles vaccine
Source: fierce